Immune Checkpoint Inhibitor-Related Aortitis Treated with Nivolumab for Esophageal Squamous Cell Carcinoma

ICI-related aortitis should be considered as a differential diagnosis for unexplained fever after ICI administration.

Authors

Institutions

Publication Details

Journal
Surgical Case Reports
Published
2025-01-01
DOI
https://doi.org/10.70352/scrj.cr.25-0177
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune Checkpoint Inhibitor-Related Aortitis Treated with Nivolumab for Esophageal Squamous Cell Carcinoma

Yusuke Suwa, Kohei Kasahara, Kenki Segami, Akikazu Yago et al.
Surgical Case Reports
Cancer Immunotherapy and Biomarkers
article

Immune Checkpoint Inhibitor-Related Aortitis Treated with Nivolumab for Esophageal Squamous Cell Carcinoma

Yusuke Suwa, Kohei Kasahara, Kenki Segami, Akikazu Yago, Masakatsu Numata, Aya Saito, Norihiro Akimoto, Sho Sato, Takafumi Kumamoto, Tsutomu Sato, Hayato Watanabe
article en

Abstract

ICI-related aortitis should be considered as a differential diagnosis for unexplained fever after ICI administration.

Surgical Case ReportsVol. 11(1)
Yokohama City University (JP)
Zero hunger
Openalex Percentile: Top 77%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.